3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Ovarian Neoplasms
2
Breast Neoplasms
2
Anatomic Stage III Breast Cancer AJCC v8
2
Anatomic Stage I Breast Cancer AJCC v8
2
Wilms Tumor
1
Triple Negative Breast Neoplasms
1
Stage I Mixed Cell Type Kidney Wilms Tumor
1
Renal Insufficiency, Chronic
1
Prostatic Neoplasms
1
Pleuropulmonary blastoma
1
Pain
1
Neuroblastoma
1
Melanoma
1
Leukemia, Hairy Cell
1
Ganglioneuroblastoma
1
Dupuytren Contracture
1
Carcinoma, Renal Cell
1
Carcinoma, Medullary
1
Carcinoma, Intraductal, Noninfiltrating
1
Anatomic Stage IV Breast Cancer AJCC v8
1
Interventions
Cyclophosphamide
15
fludarabine
12
Mycophenolic Acid
10
Standard of Care
9
venetoclax
7
Whole-Body Irradiation
7
Tacrolimus
7
Specimen Handling
7
Sirolimus
6
Practice Guidelines as Topic
6
trametinib
5
Melphalan
5
Azacitidine
5
fludarabine phosphate
4
Mesna
4
Magnetic Resonance Spectroscopy
4
Filgrastim
4
Biopsy
4
Behavior Therapy
4
Thiotepa
3
Surveys and Questionnaires
3
Radiosurgery
3
Peripheral Blood Stem Cell Transplantation
3
Interviews as Topic
3
GSK2636771
3
Educational Status
3
Cytarabine
3
Crizotinib
3
Busulfan
3
thymoglobulin
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Hematologic Neoplasms
×
High-Energy Shock Waves
×
90 days
×
Clear all
No trials found.